<DOC>
	<DOCNO>NCT01306123</DOCNO>
	<brief_summary>The main purpose study assess relative bioavailability Nascobal Nasal Spray compare IM injection cyanocobalamin ( European reference product ) .</brief_summary>
	<brief_title>Characterization Cyanocobalamin Healthy Voluteers After Intranasal Intramuscual Administration</brief_title>
	<detailed_description>This open-label , randomize , single-dose , two-way crossover study . The study consist screen visit , two 4-days confinement period follow-up telephone call . The two confinement period separate washout period least 28 day .</detailed_description>
	<mesh_term>Vitamins</mesh_term>
	<mesh_term>Vitamin B 12</mesh_term>
	<mesh_term>Hydroxocobalamin</mesh_term>
	<mesh_term>Vitamin B Complex</mesh_term>
	<criteria>Healthy female male voluteers 1840 year age BMI 18.5 30.0 kg/m2 Females pregnant lactate History clinically significant metabolic , hepatic , renal , haematological , pulmondary , cardiovascular , gastrointestinal , urological , neurological phychiatric disorder Serum vitamin B12 &lt; =250 pmol/L MMA &gt; =0.40 umol/L Evidence significant intranasal pathology Nasal congestion , allergic rhinitis upper respiratory tract infection</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>40 Years</maximum_age>
	<verification_date>October 2014</verification_date>
	<keyword>bioavailability</keyword>
	<keyword>pharmacokinetics</keyword>
	<keyword>cyanocobalamin</keyword>
	<keyword>intranasal</keyword>
	<keyword>intramuscular</keyword>
</DOC>